• Accueil >
  • Publications >
  • A novel CD7-directed antibody-drug conjugate targeting BCL-XL with potent anti-leukemic activity in T-cell acute lymphoblastic leukemia

A novel CD7-directed antibody-drug conjugate targeting BCL-XL with potent anti-leukemic activity in T-cell acute lymphoblastic leukemia

8 juin 2026Leukemia

DOI : 10.1038/s41375-026-02998-z

Auteurs

Mariana L. Oliveira, Kanokporn Nuantang, Grégoire Huré, Andrea Ávila-Ávila, Laura Bresson, Sandra Haumont, Vesela Kostova, Tibor Novak, Gaëtane Le Toumelin-Braizat, Julien Guerlesquin, Didier Demarles, Mira Merdas, Nicolas Cauquil, Oumou Goundiam, Francesca Rocchetti, Sophie Courtade-Gaiani, Damien Valour, Marwa Zerhouni, Robin Artus, Emmanuelle Douillet-Michel, Isabelle Laurent, Alice Denis, Alexandra Ovreiu, Boris Duvauchelle, Matyas Ecsedi, Frédéric Colland, Olivier Geneste, Ana Leticia Maragno, Jacques Ghysdael, Christine Tran Quang